Fibroblast growth factor regulation of neovascularization

Fibroblast growth factors are potent angiogenic inducers; however, their precise roles in angiogenesis have not been well understood. In this review, we will focus on specific roles played by fibroblast growth factors in neovascularization. Although fibroblast growth factors promote a strong angioge...

Full description

Saved in:
Bibliographic Details
Published inCurrent opinion in hematology Vol. 15; no. 3; p. 215
Main Authors Murakami, Masahiro, Simons, Michael
Format Journal Article
LanguageEnglish
Published United States 01.05.2008
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Fibroblast growth factors are potent angiogenic inducers; however, their precise roles in angiogenesis have not been well understood. In this review, we will focus on specific roles played by fibroblast growth factors in neovascularization. Although fibroblast growth factors promote a strong angiogenic response, it has been suggested that FGF-induced angiogenesis requires activation of the vascular endothelial growth factor system. Recent findings have endorsed the view of indirect contribution of fibroblast growth factor signaling to vascular development. A study using embryoid bodies demonstrated a nonimmediate role played by fibrobalst growth factor receptor 1 in vasculogenesis as vascular endothelial growth factor supplementation was sufficient to promote vascular development in Fgfr1-/- embryoid bodies. Moreover, another line of evidence indicated that myocardial fibroblast growth factor signaling is essential for mouse coronary development. The key role of fibroblast growth factor signaling in this process is Hedgehog activation, which induces vascular endothelial growth factor expression and formation of the coronary vasculature. In addition to vascular endothelial growth factor interaction, fibroblast growth factors can control neovascularization by influencing other growth factors and chemokines such as platelet-derived growth factor, hepatocyte growth factor and monocyte chemoattractant protein-1, contributing to development of mature vessels and collateral arteries. Although fibroblast growth factors are potent angiogenic factors, they may indirectly control neovascularization in concert with other growth factors. Thus, the unique role played by fibroblast growth factors might be organization of various angiogenic pathways and coordination of cell-cell interactions in this process.
AbstractList Fibroblast growth factors are potent angiogenic inducers; however, their precise roles in angiogenesis have not been well understood. In this review, we will focus on specific roles played by fibroblast growth factors in neovascularization. Although fibroblast growth factors promote a strong angiogenic response, it has been suggested that FGF-induced angiogenesis requires activation of the vascular endothelial growth factor system. Recent findings have endorsed the view of indirect contribution of fibroblast growth factor signaling to vascular development. A study using embryoid bodies demonstrated a nonimmediate role played by fibrobalst growth factor receptor 1 in vasculogenesis as vascular endothelial growth factor supplementation was sufficient to promote vascular development in Fgfr1-/- embryoid bodies. Moreover, another line of evidence indicated that myocardial fibroblast growth factor signaling is essential for mouse coronary development. The key role of fibroblast growth factor signaling in this process is Hedgehog activation, which induces vascular endothelial growth factor expression and formation of the coronary vasculature. In addition to vascular endothelial growth factor interaction, fibroblast growth factors can control neovascularization by influencing other growth factors and chemokines such as platelet-derived growth factor, hepatocyte growth factor and monocyte chemoattractant protein-1, contributing to development of mature vessels and collateral arteries. Although fibroblast growth factors are potent angiogenic factors, they may indirectly control neovascularization in concert with other growth factors. Thus, the unique role played by fibroblast growth factors might be organization of various angiogenic pathways and coordination of cell-cell interactions in this process.
Author Simons, Michael
Murakami, Masahiro
Author_xml – sequence: 1
  givenname: Masahiro
  surname: Murakami
  fullname: Murakami, Masahiro
  email: masahiro.murakami@dartmouth.edu
  organization: Angiogenesis Research Center and Section of Cardiology, Department of Medicine, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA. masahiro.murakami@dartmouth.edu
– sequence: 2
  givenname: Michael
  surname: Simons
  fullname: Simons, Michael
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18391788$$D View this record in MEDLINE/PubMed
BookMark eNo1j81OwzAQhH0ooj_wBgjlBVLWdhx7j6iiFKmoFzhXm3hdgtq4clIQPD1RgdNI30ifZqZi1MaWhbiRMJeA9u55s5pDBVKzVk4FtB7dSEwklCYvlZFjMe26dwCpEMylGEunUVrnJgKXTZVitaeuz3YpfvZvWaC6jylLvDvtqW9im8WQtRw_qKsHkprvM70SF4H2HV__5Uy8Lh9eFqt8vXl8Wtyv89oUVuXWsyo9BCkNlVQbWZMtkBwHGBZUjgrSmr1m9A6NKZmRQHuNwSkaKjUTt7_e46k6sN8eU3Og9LX9_6B-ACpVSzw
CitedBy_id crossref_primary_10_1126_scisignal_2005504
crossref_primary_10_1002_wsbm_1190
crossref_primary_10_1186_s40580_021_00285_4
crossref_primary_10_1371_journal_pone_0310557
crossref_primary_10_4161_org_6_3_12139
crossref_primary_10_3389_fbioe_2020_578140
crossref_primary_10_1161_ATVBAHA_114_304345
crossref_primary_10_3390_app11177847
crossref_primary_10_1016_j_bone_2010_02_030
crossref_primary_10_1074_jbc_M113_458489
crossref_primary_10_1111_his_12531
crossref_primary_10_1161_CIRCRESAHA_116_302953
crossref_primary_10_1152_ajpheart_00233_2008
crossref_primary_10_3390_ijms21103686
crossref_primary_10_1007_s00277_012_1583_2
crossref_primary_10_3390_ijms19102913
crossref_primary_10_1016_j_jnrt_2024_100131
crossref_primary_10_1021_acsabm_4c01527
crossref_primary_10_1161_CIRCRESAHA_113_301340
crossref_primary_10_1073_pnas_2202631119
crossref_primary_10_3389_fbioe_2020_00229
crossref_primary_10_15252_emmm_201506181
crossref_primary_10_1007_s10456_012_9253_5
crossref_primary_10_1161_CIRCRESAHA_108_184622
crossref_primary_10_1172_JCI44762
crossref_primary_10_1016_j_critrevonc_2017_02_018
crossref_primary_10_1016_j_addr_2015_11_010
crossref_primary_10_1016_j_matbio_2014_06_006
crossref_primary_10_1007_s10384_010_0801_5
crossref_primary_10_1093_cvr_cvq049
crossref_primary_10_1039_D0BM00266F
crossref_primary_10_1016_j_cjca_2011_02_005
crossref_primary_10_1186_s13287_024_03982_z
crossref_primary_10_1039_c1mb05206c
crossref_primary_10_1089_omi_2020_0023
crossref_primary_10_17116_jnevro202112107114
crossref_primary_10_1007_s10815_015_0628_6
crossref_primary_10_1016_j_bioadv_2022_213120
crossref_primary_10_1089_ten_tea_2015_0289
crossref_primary_10_1016_j_biomaterials_2020_120641
crossref_primary_10_1038_nrm_2016_87
crossref_primary_10_1007_s10517_018_4208_5
crossref_primary_10_3389_fncel_2025_1540150
crossref_primary_10_1371_journal_pone_0240332
crossref_primary_10_3390_diagnostics13061152
crossref_primary_10_1002_wdev_91
crossref_primary_10_1038_ncomms6583
crossref_primary_10_1161_CIRCRESAHA_109_200386
crossref_primary_10_1038_s12276_024_01310_2
crossref_primary_10_1016_j_ijbiomac_2024_138679
crossref_primary_10_3390_ijms25116118
crossref_primary_10_1186_s13075_023_02989_w
crossref_primary_10_1097_FJC_0000000000000107
crossref_primary_10_1002_bit_27481
crossref_primary_10_12688_f1000research_14803_1
crossref_primary_10_1038_eye_2011_246
crossref_primary_10_3390_ijms22116126
crossref_primary_10_1097_SAP_0000000000003587
crossref_primary_10_1088_1748_605X_ac1e9d
crossref_primary_10_1111_j_1365_2613_2009_00646_x
crossref_primary_10_1016_j_sxmr_2019_02_002
crossref_primary_10_1016_j_brainres_2017_03_012
crossref_primary_10_1182_blood_2011_04_347468
crossref_primary_10_1177_1538574414539397
crossref_primary_10_1016_j_ydbio_2020_12_019
crossref_primary_10_1155_2013_190486
crossref_primary_10_1016_j_lungcan_2010_08_018
crossref_primary_10_1089_ars_2012_4849
crossref_primary_10_3727_096368914X685267
crossref_primary_10_1016_j_actbio_2021_04_048
crossref_primary_10_1093_humrep_det296
crossref_primary_10_1016_j_niox_2014_09_002
crossref_primary_10_1016_j_yexcr_2013_05_022
crossref_primary_10_1038_s41598_020_63922_8
crossref_primary_10_1016_j_actbio_2019_10_018
crossref_primary_10_1172_jci_insight_132796
crossref_primary_10_1038_nri2990
crossref_primary_10_1038_s41574_021_00562_6
crossref_primary_10_17802_2306_1278_2018_7_2_89_101
crossref_primary_10_1016_j_preteyeres_2010_01_002
crossref_primary_10_1089_neu_2010_1345
crossref_primary_10_1080_02713683_2023_2252201
crossref_primary_10_1038_s41598_018_36456_3
crossref_primary_10_1111_joa_14121
crossref_primary_10_1016_j_exer_2021_108457
crossref_primary_10_3109_10715761003667554
crossref_primary_10_3389_fimmu_2022_828875
crossref_primary_10_1177_0003319712464514
crossref_primary_10_1002_adhm_202201784
crossref_primary_10_1016_j_ymthe_2021_07_014
crossref_primary_10_1016_j_reprotox_2017_07_002
crossref_primary_10_1167_iovs_64_4_32
crossref_primary_10_1155_2012_293641
crossref_primary_10_1155_2020_8868909
crossref_primary_10_1007_s12328_020_01295_1
crossref_primary_10_1038_srep38861
crossref_primary_10_1039_b921869f
crossref_primary_10_1042_CBI20100718
crossref_primary_10_1155_2019_9613923
crossref_primary_10_17709_2409_2231_2019_6_3_7
crossref_primary_10_1177_1120672120962054
crossref_primary_10_1007_s00018_013_1478_y
crossref_primary_10_1016_j_lfs_2018_09_012
crossref_primary_10_1073_pnas_2207525119
crossref_primary_10_1111_jcmm_15999
crossref_primary_10_2174_1389450120666190112145409
crossref_primary_10_3390_ijms22126496
crossref_primary_10_1007_s10456_020_09734_w
crossref_primary_10_1038_s41598_019_57040_3
crossref_primary_10_1002_ptr_6403
crossref_primary_10_1093_cvr_cvu239
crossref_primary_10_1161_ATVBAHA_112_252544
crossref_primary_10_1186_s13148_020_00942_1
crossref_primary_10_3390_ijms24065188
crossref_primary_10_1186_s13287_024_03935_6
crossref_primary_10_3390_cancers14071844
crossref_primary_10_2139_ssrn_4194124
crossref_primary_10_3390_ijms20123004
crossref_primary_10_1038_nbt_1845
crossref_primary_10_1016_j_devcel_2024_09_012
crossref_primary_10_1002_jbm_a_37434
crossref_primary_10_1016_j_bbrc_2013_01_013
crossref_primary_10_1016_j_actbio_2014_09_028
crossref_primary_10_1016_j_biopha_2017_08_059
crossref_primary_10_3389_fdmed_2023_1239149
crossref_primary_10_1053_j_semnuclmed_2019_01_004
crossref_primary_10_1007_s11481_019_09865_y
crossref_primary_10_1007_s13770_020_00258_4
crossref_primary_10_1016_j_lfs_2019_04_040
crossref_primary_10_1002_btpr_1883
crossref_primary_10_1242_bio_20133988
crossref_primary_10_1016_j_ctrv_2011_04_003
crossref_primary_10_1155_2011_274628
crossref_primary_10_1016_j_joms_2013_03_009
crossref_primary_10_1507_endocrj_EJ18_0537
crossref_primary_10_1242_dmm_010413
crossref_primary_10_3390_ijms17111822
crossref_primary_10_1051_medsci_20163204015
crossref_primary_10_3390_biomedicines9040432
crossref_primary_10_1074_jbc_M111_296806
crossref_primary_10_2217_fon_2020_0726
crossref_primary_10_3390_cancers15133375
crossref_primary_10_3390_ijms22137233
crossref_primary_10_1161_CIRCRESAHA_111_249847
crossref_primary_10_3390_cells8121624
crossref_primary_10_1097_ICO_0b013e31823f8b5a
crossref_primary_10_1016_j_smim_2018_02_002
crossref_primary_10_1002_ptr_7023
crossref_primary_10_1146_annurev_physiol_021909_135833
crossref_primary_10_3390_cells10113242
crossref_primary_10_1158_1541_7786_MCR_10_0168
crossref_primary_10_1093_stcltm_szac052
crossref_primary_10_1016_j_exer_2018_07_006
crossref_primary_10_3390_ijms19010299
crossref_primary_10_1161_CIRCRESAHA_109_209809
crossref_primary_10_1161_CIRCRESAHA_110_231910
crossref_primary_10_3923_ijcr_2014_96_105
crossref_primary_10_1007_s12016_021_08851_8
crossref_primary_10_1007_s00259_016_3480_8
crossref_primary_10_1182_blood_2011_12_399659
crossref_primary_10_1002_jcb_24621
crossref_primary_10_1182_blood_2010_12_326017
crossref_primary_10_1016_j_biomaterials_2015_12_025
crossref_primary_10_1016_j_devcel_2010_08_007
crossref_primary_10_1126_scitranslmed_3009332
crossref_primary_10_1007_s10456_012_9275_z
crossref_primary_10_1002_dvdy_22460
crossref_primary_10_1007_s00395_017_0631_4
crossref_primary_10_1016_j_matbio_2015_02_003
crossref_primary_10_1016_j_progpolymsci_2014_01_001
crossref_primary_10_1016_j_biopha_2023_115306
crossref_primary_10_1111_cpr_12209
crossref_primary_10_1111_jcmm_70324
crossref_primary_10_14245_ns_1836216_108
crossref_primary_10_1186_s13046_023_02902_y
crossref_primary_10_1186_2050_490X_2_6
crossref_primary_10_1210_jc_2009_2049
crossref_primary_10_1016_j_pharmthera_2023_108522
crossref_primary_10_1007_s11883_015_0509_6
crossref_primary_10_1074_jbc_M109_033472
crossref_primary_10_1159_000442381
crossref_primary_10_1111_ger_12154
crossref_primary_10_1182_blood_2010_11_316752
crossref_primary_10_3340_jkns_2012_52_1_7
crossref_primary_10_3389_fendo_2015_00193
crossref_primary_10_3390_cancers16061113
crossref_primary_10_1016_j_rbmo_2021_06_019
crossref_primary_10_1016_j_ccr_2013_02_019
crossref_primary_10_1002_adma_202309797
crossref_primary_10_1074_mcp_M111_012526
crossref_primary_10_1369_0022155412464638
crossref_primary_10_1016_j_jbc_2021_101149
crossref_primary_10_1002_cbin_10838
crossref_primary_10_1007_s00784_016_1759_6
crossref_primary_10_1371_journal_pone_0138801
crossref_primary_10_1371_journal_pone_0140786
crossref_primary_10_1161_ATVBAHA_120_314517
crossref_primary_10_1007_s00109_009_0463_2
crossref_primary_10_1016_j_molmed_2015_12_006
crossref_primary_10_1039_D1BM00162K
crossref_primary_10_1089_hum_2020_235
crossref_primary_10_1101_cshperspect_a041156
crossref_primary_10_1016_j_critrevonc_2024_104464
crossref_primary_10_3390_cells13161384
crossref_primary_10_3389_fendo_2023_1287789
crossref_primary_10_3390_jcm9051325
crossref_primary_10_1007_s13346_012_0122_y
crossref_primary_10_1186_s12915_021_01103_3
crossref_primary_10_1016_j_msec_2020_111741
crossref_primary_10_1093_glycob_cwac029
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1097/MOH.0b013e3282f97d98
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 18391788
Genre Journal Article
Review
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: HL62289
– fundername: NHLBI NIH HHS
  grantid: R01 HL053793
– fundername: NHLBI NIH HHS
  grantid: HL53793
– fundername: NHLBI NIH HHS
  grantid: R01 HL062289
GroupedDBID ---
.-D
.3C
.XZ
.Z2
01Q
0R~
4Q1
4Q2
4Q3
53G
5GY
5VS
6PF
71W
8L-
AAAAV
AAHPQ
AAIQE
AAJCS
AAMTA
AARTV
AASCR
AAWTL
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFMFG
AFNMH
AHQNM
AHQVU
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
BS7
C45
CAG
CGR
COF
CS3
CUY
CVF
DIWNM
DU5
DUNZO
E.X
EBS
ECM
EEVPB
EIF
EJD
EX3
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IN~
IPNFZ
JF9
JG8
JK3
JK8
K8S
KD2
L-C
LEELO
N9A
NPM
N~M
O9-
OAG
OAH
OCUKA
ODA
ODMTH
OHYEH
OLC
OLG
OPUJH
ORVUJ
OUVQU
OVD
OVDKG
OVDNE
OVKID
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
R58
RIG
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XO3
XXN
XYM
YFH
YOC
ZFV
ZZMQN
ID FETCH-LOGICAL-c5472-7de26d0f115a6ac51ca749a8ef0178b8a4a33ed3e9d89556ee9a03d39f82aa332
ISSN 1065-6251
IngestDate Fri May 30 11:01:33 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5472-7de26d0f115a6ac51ca749a8ef0178b8a4a33ed3e9d89556ee9a03d39f82aa332
OpenAccessLink http://doi.org/10.1097/MOH.0b013e3282f97d98
PMID 18391788
ParticipantIDs pubmed_primary_18391788
PublicationCentury 2000
PublicationDate 2008-May
PublicationDateYYYYMMDD 2008-05-01
PublicationDate_xml – month: 05
  year: 2008
  text: 2008-May
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Current opinion in hematology
PublicationTitleAlternate Curr Opin Hematol
PublicationYear 2008
SSID ssj0012905
Score 2.3480155
SecondaryResourceType review_article
Snippet Fibroblast growth factors are potent angiogenic inducers; however, their precise roles in angiogenesis have not been well understood. In this review, we will...
SourceID pubmed
SourceType Index Database
StartPage 215
SubjectTerms Animals
Cell Communication
Fibroblast Growth Factors - physiology
Humans
Mice
Neovascularization, Physiologic - physiology
Signal Transduction
Vascular Endothelial Growth Factor A - physiology
Title Fibroblast growth factor regulation of neovascularization
URI https://www.ncbi.nlm.nih.gov/pubmed/18391788
Volume 15
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3PS8MwFMeDUxAv4u_f0oO3UV2bpk2OIo4hTC8b7DbSJnFD1o7Zk3-9L036Y3PC9FJGA2HdJ3t83-v7gdBdEoLoxp5yiaSJG3A_dpkIuRuHPpzmgHWSIt7Rfw17w-BlREb1mLuiuiSP75OvtXUl_6EK94CrrpL9A9lqU7gBn4EvXIEwXDdi3AVfN4tB_-btd3Cn84kdn9NemAnzVgymsko4tVWXTUladmjSlVM28bFo5LoUbwce_IPPpqa855NPpousCs4Abhu0buTgl5EEWuftWeMHcsQFf8hbso6kcQrwkqkja02wae3bf-uVMVZw6hSLhBk23aAynxVYtETzIrrB6kpj7HKphVrgIuiZpzpQY18g-azIXq0eqayaZNHDuq-me8fa7Vb8i0JnDA7QvnUQnEdD-xBtyfQI7fZtCsQxYjV0x0B3DHSnhu5kyvkJ_QQNu8-Dp55r51-4CQkicHyE9EPRUSDaecgT4iU8ChinUoEZpTHlAcdYCiyZoIyQUErGO1hgpqjPYck_Rdtplspz5CjhgRjClPBA6nZFXLfpl34AuyjMcHyBzsxDj-emycm4_Dkuf125Qnv1KbpGOwr-VfIGJFoe3xYwvgFPzTqM
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fibroblast+growth+factor+regulation+of+neovascularization&rft.jtitle=Current+opinion+in+hematology&rft.au=Murakami%2C+Masahiro&rft.au=Simons%2C+Michael&rft.date=2008-05-01&rft.issn=1065-6251&rft.volume=15&rft.issue=3&rft.spage=215&rft_id=info:doi/10.1097%2FMOH.0b013e3282f97d98&rft_id=info%3Apmid%2F18391788&rft_id=info%3Apmid%2F18391788&rft.externalDocID=18391788
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1065-6251&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1065-6251&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1065-6251&client=summon